Routine cross-matching places substantial demands on limited blood resources. The primary objective of this study was to identify patients with hip fractures at risk of transfusion, which may allow implementation of a more selective cross-matching policy. We also sought to determine the hemoglobin level that triggered a transfusion, the rate of urgent (intraoperative) transfusions, and these patients' characteristics. We reviewed 124 consecutive patients admitted with hip fractures. Patients' clinical and radiologic details, transfusion rates, timing of transfusion, and preoperative and postoperative hemoglobin were reviewed. Older age, low admission hemoglobin, and peritrochanteric fractures were identified as risk factors for transfusion. Eighty-six percent of patients who received transfusions had two or more risk factors, compared with 48% of the total population. The mean hemoglobin that triggered a transfusion was 7.8 g/dL. Although 30% (37/124) of patients received transfusions, only 5% (six of 124) received transfusions intraoperatively, and the majority of these patients (five of six) had at least two risk factors of transfusion. Routine cross-matching for patients with hip fractures requiring surgery can safely be converted to cross-matching on demand in all but high-risk patients. Restrictive cross-matching policies would improve costs in healthcare delivery and prevent unnecessary use of blood resources.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/01.blo.0000173253.59827.7b | DOI Listing |
Cureus
December 2024
Trauma and Orthopaedics, University Hospitals Sussex National Health Service (NHS) Foundation Trust, Sussex, GBR.
Background: The aim of the study is to identify the potential risk factors for postoperative AKI in hip fracture patients.
Design And Methods: Using our local neck of femur (NOF) registration data, patient details were selected using inclusion and exclusion criteria. Electronic records of patients were assessed retrospectively, including blood results, radiological investigations, clinical documentation, and drug charts.
Nurs Res Pract
January 2025
Department of Orthopedic Surgery, Kyungpook National University, Kyungpook National University Hospital, Daegu, Republic of Korea.
This study aimed to investigate the independent association between the fear of falling (FOF) and frailty in Korean older adults after hip fracture surgery. The study included 149 participants. Participants were asked to provide general characteristics and complete walking speed, grip strength, frailty, and Short Falls Efficacy Scale-International assessments.
View Article and Find Full Text PDFJ Orthop Case Rep
January 2025
Department of Orthopedic Surgery, Mayo Clinic College of Medicine and Science, Mayo Clinic, Phoenix AZ, USA.
Introduction: Femoral nerve injury is a recognized complication of abdominal, pelvic, and orthopedic surgeries. It can also occur due to pelvic fractures, intra-abdominal trauma, and hip injuries. These injuries often result in pain, weakness, and difficulty with ambulation, significantly impacting a patient's quality of life.
View Article and Find Full Text PDFJ Orthop Case Rep
January 2025
Department of Orthopaedics, Bombay Hospital, Mumbai, Maharashtra, India.
Introduction: The occurrence of non-traumatic bilateral femoral neck fractures is exceedingly rare, and their manifestation subsequent to an epileptic attack is an uncommon entity with very few cases reported globally.
Case Report: We present the positive outcome of a 68-year-old man who underwent staged bilateral constrained total hip arthroplasty following a fracture resulting from a generalized seizure. This unconventional decision was justified based on several factors, including fracture pattern, bone quality, seizure history, and advanced tribology.
Endocrinol Metab (Seoul)
January 2025
Division of Endocrinology & Metabolism, Department of Internal Medicine, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Osteoporosis management in post-menopausal women focuses on fracture prevention, with denosumab as a key therapeutic option. Despite its proven efficacy in reducing fracture risk and increasing bone mineral density (BMD) over 10 years, its long-term impact remains uncertain. We evaluated the literature on its efficacy and safety beyond the initial decade.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!